Dynavax Technologies | Costo Del Venduto



Cost Of Sales Cambiamento Data
AbbVie USD 4B 394M 2025-03
Adma Biologics USD 54.22M 5.96M 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Dynavax Technologies USD 13.41M 326K 2024-12
Gilead Sciences USD 1.54B 41M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Dynavax Technologies Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.